Why Is Seagen Stock Trading Higher Today?
Seagen Inc (NASDAQ: SGEN) and Astellas Pharma Inc (OTC: ALPMF) (OTC:
What’s Going On With Neurology Focused Taysha Gene Therapies Stock Today?
Astellas Pharma Inc (OTC: ALPMY) (OTC: ALPMF) has elected
Astellas Pharma Licenses Promising Gene Therapy KT430 from Kate Therapeutics Amidst Clinical Hurdles
Astellas Pharma Inc (OTC: ALPMF) (OTC: ALPMY) decided to license and advance a gene therapy from Kate Therapeutics for a debilitating muscle disorder known as
Astellas’ Menopause Drug Sores FDA Approval, After Regulatory Setback
The FDA on Friday approved Japanese drugmaker Astellas Pharma Inc’s (OTC: ALPMY) (OTC: ALPMF) Veozah (fezolinetant) for hot flashes
Pfizer, Astellas’ Xtandi Combo Therapy Cuts Risk Of Metastasis, Death In Prostate Cancer By 58%
Astellas Pharma Inc (OTC: ALPMY) and Pfizer Inc (NYSE: PFE) announced
Astellas Pharma Acquires Iveric Bio For $5.9B To Focus On ‘Blindness & Regeneration’
Japanese healthcare company Astellas Pharma Inc (OTC: ALPMY) has agreed to buy Iveric Bio Inc (NASDAQ: ISEE) for $40.00 per share in cash for a total equity value of
FDA Approves Merck’s Keytruda Combined With Seagen/Astellas’s Padcev For Advanced Urothelial Cancer
The FDA approved Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in combination with Astellas Pharma Inc (OTC:ALMPF) & Seagen Inc’s (NASDAQ:SGEN) Padcev (enfortumab vedotin-ejfv) locally…
AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners
CytomX Therapeutics Inc (NASDAQ:CTMX) will weigh its options for CX-2029, a CD71-directed antibody-drug conjugate, after AbbVie Inc (NYSE:ABBV) decided…
Japanese Government Urges China To Release Astellas Pharma’s Employee
The Japanese government is reportedly seeking the release of an employee of Japanese pharma company Astellas Pharma Inc (OTC: ALPMF), detained by Chinese authorities.
The reasons why the person was detained are still unknown.